Hudson River Biotechnology
The company provides a DNA-free CRISPR technology platform called BioMaas to optimize plant breeding for crop producers. This automated platform enables multi-trait targeting to improve crop resilience and yield without the introduction of foreign DNA. The service is designed to be crop and enzyme agnostic, delivering completed products within a 12-18 month timeframe.
Visit websiteWageningen, Netherlands
Agritech
Biotechnology
Gene Editing
Funding summary
- Total raised
- €5.0M
- Funding rounds
- 2
Investors in Hudson River Biotechnology
Investors on record for Hudson River Biotechnology. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Hudson River Biotechnology?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors